OCUGEN, INC. Basic Shares Outstanding (Weighted Average)
OCUGEN, INC. (OCGN) reported Basic Shares Outstanding (Weighted Average) of 338.68 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- OCUGEN, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 338.68M shares, a 15.96% increase year-over-year.
- OCUGEN, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 327.54M shares, a 12.17% increase year-over-year.
- OCUGEN, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-06-30 was 292.07M shares, a 13.49% increase year-over-year.
- OCUGEN, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-03-31 was 292.00M shares, a 13.51% increase year-over-year.
- OCUGEN, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 244.33M shares, a 13.85% increase from fiscal 2022.
- OCUGEN, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 214.60M shares, a 10.04% increase from fiscal 2021.
- OCUGEN, INC. weighted average number of shares outstanding, basic for fiscal 2021 was 195.01M shares, a 73.75% increase from fiscal 2020.
- OCUGEN, INC. weighted average number of shares outstanding, basic for fiscal 2020 was 112.24M shares, a 707.81% increase from fiscal 2019.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 338.68M shares 10-Q · filed 2026-08-06 | 333.14M shares 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | 327.54M shares 10-Q · filed 2026-05-08 | |||
| 2025-06-30 | 292.07M shares 10-Q · filed 2026-08-06 | 292.03M shares 10-Q · filed 2026-08-06 | ||
| 2025-03-31 | 292.00M shares 10-Q · filed 2026-05-08 | |||
| 2024-06-30 | 257.35M shares 10-Q · filed 2024-08-08 | 257.29M shares 10-Q · filed 2024-08-08 | 257.08M shares derived: average of 3 quarters · filed 2024-08-08 | 256.93M shares derived: average of 4 quarters · filed 2024-08-08 |
| 2024-03-31 | 257.23M shares 10-Q · filed 2024-05-14 | 256.94M shares derived: average of 2 quarters · filed 2024-05-14 | 256.79M shares derived: average of 3 quarters · filed 2024-05-14 | 252.17M shares derived: average of 4 quarters · filed 2024-08-08 |
| 2023-12-31 | 256.64M shares derived: 10-K 12 month − 10-K 9 month · filed 2024-04-16 | 256.57M shares derived: average of 2 quarters · filed 2024-04-16 | 250.48M shares derived: average of 3 quarters · filed 2024-08-08 | 244.33M shares 10-K · filed 2024-04-16 |
| 2023-09-30 | 256.49M shares 10-K · filed 2024-04-16 | 247.40M shares derived: average of 2 quarters · filed 2024-08-08 | 240.22M shares 10-K · filed 2024-04-16 | 235.12M shares derived: average of 4 quarters · filed 2024-08-08 |
| 2023-06-30 | 238.31M shares 10-Q · filed 2024-08-08 | 231.95M shares 10-Q · filed 2024-08-08 | 227.99M shares derived: average of 3 quarters · filed 2024-08-08 | 225.14M shares derived: average of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | 225.52M shares 10-Q · filed 2024-05-14 | 222.83M shares derived: average of 2 quarters · filed 2024-05-14 | 220.75M shares derived: average of 3 quarters · filed 2024-05-14 | 219.53M shares derived: average of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | 220.13M shares derived: 10-K 12 month − 10-K 9 month · filed 2024-04-16 | 218.36M shares derived: average of 2 quarters · filed 2024-04-16 | 217.53M shares derived: average of 3 quarters · filed 2024-04-16 | 214.60M shares 10-K · filed 2024-04-16 |
| 2022-09-30 | 216.59M shares 10-K · filed 2024-04-16 | 216.23M shares derived: average of 2 quarters · filed 2024-04-16 | 212.76M shares 10-K · filed 2024-04-16 | 209.35M shares derived: average of 4 quarters · filed 2024-04-16 |
| 2022-06-30 | 215.86M shares 10-K · filed 2024-04-16 | 210.81M shares 10-K · filed 2024-04-16 | 206.94M shares derived: average of 3 quarters · filed 2024-04-16 | 204.90M shares derived: average of 4 quarters · filed 2024-04-16 |
| 2022-03-31 | 205.69M shares 10-K · filed 2024-04-16 | 202.47M shares derived: average of 2 quarters · filed 2024-04-16 | 201.25M shares derived: average of 3 quarters · filed 2024-04-16 | 199.83M shares derived: average of 4 quarters · filed 2024-04-16 |
| 2021-12-31 | 199.25M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | 199.02M shares derived: average of 2 quarters · filed 2023-02-28 | 197.87M shares derived: average of 3 quarters · filed 2023-02-28 | 195.01M shares 10-K · filed 2023-02-28 |
| 2021-09-30 | 198.79M shares 10-Q · filed 2022-11-08 | 197.18M shares derived: average of 2 quarters · filed 2022-11-08 | 193.60M shares 10-Q · filed 2022-11-08 | 187.83M shares derived: average of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | 195.57M shares 10-Q · filed 2022-08-05 | 190.96M shares 10-Q · filed 2022-08-05 | 184.17M shares derived: average of 3 quarters · filed 2022-08-05 | 173.53M shares derived: average of 4 quarters · filed 2022-08-05 |
| 2021-03-31 | 186.30M shares 10-Q · filed 2022-05-06 | 178.48M shares derived: average of 2 quarters · filed 2022-05-06 | 166.18M shares derived: average of 3 quarters · filed 2022-05-06 | 145.52M shares derived: average of 4 quarters · filed 2022-05-06 |
| 2020-12-31 | 170.65M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | 156.12M shares derived: average of 2 quarters · filed 2022-02-28 | 131.93M shares derived: average of 3 quarters · filed 2022-02-28 | 112.24M shares 10-K · filed 2022-02-28 |
| 2020-09-30 | 141.59M shares 10-Q · filed 2021-11-09 | 112.56M shares derived: average of 2 quarters · filed 2021-11-09 | 92.76M shares 10-Q · filed 2021-11-09 | |
| 2020-06-30 | 83.54M shares 10-Q · filed 2021-08-06 | 68.08M shares 10-Q · filed 2021-08-06 | ||
| 2019-12-31 | 13.89M shares 10-K · filed 2022-02-28 | |||
| 2018-12-31 | 59.42M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | 44.58M shares derived: average of 2 quarters · filed 2019-03-22 | 36.40M shares 10-K · filed 2019-03-22 | |
| 2018-09-30 | 29.74M shares 10-Q · filed 2018-11-08 | 28.72M shares 10-Q · filed 2018-11-08 | ||
| 2017-12-31 | 24.02M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | 23.29M shares derived: average of 2 quarters · filed 2019-03-22 | 22.67M shares 10-K · filed 2019-03-22 | |
| 2017-09-30 | 22.55M shares 10-Q · filed 2018-11-08 | 22.22M shares 10-Q · filed 2018-11-08 | ||
| 2016-12-31 | 14.26M shares 10-K · filed 2018-03-15 | |||
| 2015-12-31 | 52.92M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | 26.46M shares derived: average of 2 quarters · filed 2017-03-16 | 17.64M shares derived: average of 3 quarters · filed 2017-03-16 | 13.23M shares 10-K · filed 2017-03-16 |
| 2015-09-30 | 0.00 shares 10-Q · filed 2015-11-12 | 0.00 shares derived: average of 2 quarters · filed 2015-11-12 | 0.00 shares 10-Q · filed 2015-11-12 | |
| 2015-06-30 | 0.00 shares 10-Q · filed 2015-08-12 | 0.00 shares 10-Q · filed 2015-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |